No abstract

Demand for land to grow corn for ethanol increased in the United States by 4.9 million hectares between 2005 and 2008, with wide-ranging effects on wildlife, including habitat loss. Depending on how biofuels are made, additional production could have similar impacts. We present a framework for assessing the impacts of biofuels on wildlife, and we use this framework to evaluate the impacts of existing and emerging biofuels feedstocks on grassland wildlife. Meeting the growing demand for biofuels while avoiding negative impacts on wildlife will require either biomass sources that do not require additional land (e.g., wastes, residues, cover crops, algae) or crop production practices that are compatible with wildlife. Diverse native prairie offers a potential approach to hioenergy production (including fuel, electricity, and heat) that is compatible with wildlife. Additional research is required to assess the compatibility of wildlife with different composition, inputs, and harvest management approaches, and to address concerns over prairie yields versus the yields of other biofuel crops.

No abstract

Deposition of carotenoids in saponified paprika (SP) and unsaponified oleoresin paprika (OP) in egg yolks as well as the dietary level for desired pigmentation were evaluated. Sixty‐four hens on a carotenoid‐depletion diet were divided into two replicated groups of each of eight dietary treatments containing from 0 to 16 mg paprika carotenoids per kg feed. Colour and the carotenoid content of egg yolk increased linearly (P<0·01) with the amounts of paprika carotenoids in the diets. The colours of egg yolks from hens fed similar concentra‐tions of OP or SP were not significantly different (P<0·01). A low dose (4 mg kg−1) of OP or SP provided yolk colour equivalent to the colour of eggs in supermarkets. High‐performance liquid chromatographic analyses showed that carotenoids deposited in the yolk are in the free alcohol form, regardless of the form of carotenoids in the diet. Capsanthin, the predominant carotenoid in paprika, was deposited in egg yolk less efficiently than zeaxanthin and lutein.

Data on 22 subjects treated with fluoxetine suggest that magnetic resonance spectroscopy (MRS) of fluorine-19 can measure brain concentrations of fluoxetine/norfluoxetine in vivo. Fluoxetine accumulates in the human brain relative to plasma, with brain concentrations of fluoxetine/norfluoxetine ranging up to 10.7 micrograms/ml. Brain concentrations may reach a plateau between 6 and 8 months of treatment. The apparent concentration in brain relative to plasma is 20:1, roughly parallel to brain antidepressant concentration ratios in animal studies.

No abstract

The Eastern Population (EP) of greater sandhill cranes (Antigone canadensis tabida; cranes) is expanding in size and geographic range. Little information exists regarding the geographic extent of breeding, migration, and wintering ranges, migration chronology, or use of staging areas for cranes in the EP. To obtain these data, we attached solar global positioning system (GPS) platform transmitting terminals (PTTs) to 42 sandhill cranes and monitored daily locations from December 2009 through August 2014. On average, tagged cranes settled in summer areas during late‐March in Minnesota (7%), Wisconsin (29%), Michigan, USA (21%), and Ontario, Canada (38%) and arrived at their winter terminus beginning mid‐December in Indiana (15%), Kentucky (3%), Tennessee (45%), Georgia (5%), and Florida (32%). Cranes initiated spring migration beginning mid‐February to their respective summer areas on routes similar to those used during fall migration. Twenty‐five marked cranes returned to the same summer area after a second spring migration, of which 19 (76%) settled <3 km from the estimated mean center of the summer area of the previous year. During the 2010–2012 United States Fish and Wildlife Service (USFWS) Cooperative Fall Abundance Survey for cranes in the EP, we estimated that approximately 29–31% of cranes that summered in both Wisconsin and the Lower Peninsula of Michigan were not in areas included in the survey. The information we collected on crane movements provides insight into distribution and migration chronology that will aid in assessment of the current USFWS fall survey. In addition, information on specific use sites can assist state and federal managers to identify and protect key staging and winter areas particularly during current and future recreational harvest seasons. © 2017 The Wildlife Society.

Deficits in N-methyl-D-aspartate receptor (NMDAR) function are increasingly linked to persistent negative symptoms and cognitive deficits in schizophrenia. Accordingly, clinical studies have been targeting the modulatory site of the NMDA receptor, based on the decreased function of NMDA receptor, to see whether increasing NMDA function can potentially help treat the negative and cognitive deficits seen in the disease. Glycine and D-serine are endogenous ligands to the NMDA modulatory site, but since high doses are needed to affect brain levels, related compounds are being developed, for example glycine transport (GlyT) inhibitors to potentially elevate brain glycine or targeting enzymes, such as D-amino acid oxidase (DAAO) to slow the breakdown and increase the brain level of D-serine. In the present study we further evaluated the effect of DAAO inhibitors 5-chloro-benzo[d]isoxazol-3-ol (CBIO) and sodium benzoate (NaB) in a phencyclidine (PCP) rodent mouse model to see if the inhibitors affect PCP-induced locomotor activity, alter brain D-serine level, and thereby potentially enhance D-serine responses. D-Serine dose-dependently reduced the PCP-induced locomotor activity at doses above 1000 mg/kg. Acute CBIO (30 mg/kg) did not affect PCP-induced locomotor activity, but appeared to reduce locomotor activity when given with D-serine (600 mg/kg); a dose that by itself did not have an effect. However, the effect was also present when the vehicle (Trappsol®) was tested with D-serine, suggesting that the reduction in locomotor activity was not related to DAAO inhibition, but possibly reflected enhanced bioavailability of D-serine across the blood brain barrier related to the vehicle. With this acute dose of CBIO, D-serine level in brain and plasma were not increased. Another weaker DAAO inhibitor sodium benzoate (NaB) (400 mg/kg), and NaB plus D-serine also significantly reduced PCP-induced locomotor activity, but without affecting plasma or brain D-serine level, arguing against a DAAO-mediated effect. However, NaB reduced plasma L-serine and based on reports that NaB also elevates various plasma metabolites, for example aminoisobutyric acid (AIB), a potential effect via the System A amino acid carrier may be involved in the regulation of synaptic glycine level to modulate NMDAR function needs to be investigated. Acute ascorbic acid (300 mg/kg) also inhibited PCP-induced locomotor activity, which was further attenuated in the presence of D-serine (600 mg/kg). Ascorbic acid may have an action at the dopamine membrane carrier and/or altering redox mechanisms that modulate NMDARs, but this needs to be further investigated. The findings support an effect of D-serine on PCP-induced hyperactivity. They also offer suggestions on an interaction of NaB via an unknown mechanism, other than DAAO inhibition, perhaps through metabolomic changes, and find unexpected synergy between D-serine and ascorbic acid that supports combined NMDA glycine- and redox-site intervention. Although mechanisms of these specific agents need to be det...